<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03953469</url>
  </required_header>
  <id_info>
    <org_study_id>2019-02-01</org_study_id>
    <nct_id>NCT03953469</nct_id>
  </id_info>
  <brief_title>Short-term Effects of Passiflora and Meditation on Blood Pressure and Heart Rate</brief_title>
  <official_title>Investigating the Short-term Effects of Passiflora Incarnate and Mobile Audio-guided Meditation on Blood Pressure and Heart Rate in Naturopathic Medical Students</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bridgeport</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bridgeport</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is intended to study the effects of one-time acute dosing of a solid extract of
      Passiflora incarnata, also known as Passionflower, on blood pressure and heart rate in
      students. Our hypothesis is that blood pressure levels and heart rates will decrease
      significantly in response to Passiflora incarnata.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">August 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>There are two arms. One arm involves consuming a placebo. The second arm involves taking the Passionflower. Neither the primary investigator nor the participant will know which treatment they are taking.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood pressure between baseline and 15 minutes</measure>
    <time_frame>15 minutes</time_frame>
    <description>Change in blood pressure between baseline and 15 minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in heart rate between baseline and 15 minutes</measure>
    <time_frame>15 minutes</time_frame>
    <description>Change in heart rate between baseline and 15 minutes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Heart Rate Fast</condition>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>(a) Baseline blood pressure readings and one heart rate reading taken after at least 5 minutes of rest time without talking, eating, or caffeine consumption.
b) will be given 1/4 tsp of blackstrap molasses placebo. Subjects may not consume caffeine or eat food during this time.
(c) blood pressure readings and one heart rate will be taken 15 minutes after the baseline reading.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Baseline blood pressure readings and one heart rate reading taken after at least 5 minutes of rest time without talking, eating food, or caffeine consumption.
15 minutes after examination - will be given 1/8 tsp (900mg) of Passiflora incarnata solid extract by Wise Woman Herbals mixed with 1/8 tsp of blackstrap molasses to mask the taste.
blood pressure readings and one heart rate will be taken 15 minutes after the baseline reading.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Passiflora incarnata</intervention_name>
    <description>One-time administration of 1/8 tsp solid extract Passiflora incarnata providing 900mg of Passiflora incarnata</description>
    <arm_group_label>Group II</arm_group_label>
    <other_name>Passionflower</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: all University of Bridgeport students are invited to participate

        Exclusion Criteria:

          1. Those taking hypertensive medication

          2. Those taking anti-anxiety medication, including MAOI medication

          3. Those taking blood-thinning medication

          4. Those who are pregnant

          5. Those who could be pregnant

          6. Those who will have surgery 2 weeks before the research date

          7. Those who are scheduled to have surgery 2 weeks after the research date

          8. Those who have consumed caffeine, food/tyramine containing foods, stimulant
             medication, cold medicine, decongestant medicine, antihistamine medicine, cough
             suppressants, alcoholic beverages, or stimulant energy drinks within 2 hours before
             the study period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly Sanders, ND</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bridgeport</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Sanders, ND</last_name>
    <phone>2035764425</phone>
    <email>kimbersa@bridgeport.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark Mattie, MD, PhD</last_name>
    <email>mmattie@bridgeport.edu</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 9, 2019</study_first_submitted>
  <study_first_submitted_qc>May 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 16, 2019</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bridgeport</investigator_affiliation>
    <investigator_full_name>Kimberly Sanders</investigator_full_name>
    <investigator_title>Principal Investigator, Assistant Professor of Clinical Sciences</investigator_title>
  </responsible_party>
  <keyword>passionflower</keyword>
  <keyword>heart rate</keyword>
  <keyword>blood pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT03953469/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 28, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/69/NCT03953469/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

